[CAPR] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[CAPR] Capricor Therapeutics, Inc.
Announcement Date
08-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 21.46%
YoY- 61.15%
Quarter Report
CAPR's Result
CAPR's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 1,592 0 17 142 219 313 684 15.11%
PBT -6,371 -3,932 -3,910 -1,607 -4,136 -2,735 -5,333 3.00%
Tax -107 -80 -40 -64 0 74 72 -
NP -6,264 -3,932 -3,910 -1,607 -4,136 -2,735 -5,333 2.71%
Tax Rate - - - - - - - -
Total Cost 7,856 3,932 3,927 1,749 4,355 3,048 6,017 4.54%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -393.60 0.00 -23,187.59 -1,130.84 -1,886.52 -873.04 -780.20 -10.77%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -0.26 -0.17 -0.20 -0.43 -1.35 -1.17 -2.92 -33.16%
EPS Diluted -0.26 -0.17 -0.20 -0.43 -1.35 -1.17 -2.92 -33.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.